Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $13.6 million.

  • Dna X's Accumulated Expenses fell 4106.28% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 4106.28%. This contributed to the annual value of $20.9 million for FY2024, which is 6985.37% up from last year.
  • Per Dna X's latest filing, its Accumulated Expenses stood at $13.6 million for Q3 2025, which was down 4106.28% from $12.2 million recorded in Q2 2025.
  • Dna X's Accumulated Expenses' 5-year high stood at $23.1 million during Q3 2024, with a 5-year trough of $7.9 million in Q2 2021.
  • Over the past 5 years, Dna X's median Accumulated Expenses value was $11.4 million (recorded in 2021), while the average stood at $12.5 million.
  • Per our database at Business Quant, Dna X's Accumulated Expenses plummeted by 5311.63% in 2021 and then skyrocketed by 11790.09% in 2024.
  • Over the past 5 years, Dna X's Accumulated Expenses (Quarter) stood at $11.4 million in 2021, then dropped by 5.82% to $10.7 million in 2022, then increased by 15.04% to $12.3 million in 2023, then skyrocketed by 69.85% to $20.9 million in 2024, then crashed by 34.75% to $13.6 million in 2025.
  • Its Accumulated Expenses was $13.6 million in Q3 2025, compared to $12.2 million in Q2 2025 and $15.1 million in Q1 2025.